Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionalkaline phosphatase activity

ALPI ALPP

1.23e-046582GO:0004035
GeneOntologyBiologicalProcessestablishment of skin barrier

FLG TP63 HRNR FLG2

4.58e-0641564GO:0061436
GeneOntologyCellularComponentkeratohyalin granule

FLG HRNR FLG2

2.24e-075603GO:0036457
GeneOntologyCellularComponentcornified envelope

FLG KLK7 RPTN HRNR FLG2

1.60e-0669605GO:0001533
HumanPhenoShort attention span

FLG KANSL1 SETD5 NEXMIF RFX7 SPEN BBS12 FOXG1 WAC

1.02e-04517219HP:0000736
HumanPhenoReduced attention regulation

FLG KANSL1 SETD5 NEXMIF RFX7 SPEN BBS12 FOXG1 WAC

1.17e-04526219HP:5200044
HumanPhenoAbnormal size of the palpebral fissures

KANSL1 SETD5 TP63 RFX7 SPEN FOXG1 WAC

1.25e-04298217HP:0200007
HumanPhenoAttention deficit hyperactivity disorder

FLG KANSL1 SETD5 NEXMIF RFX7 SPEN FOXG1 WAC

1.38e-04413218HP:0007018
HumanPhenoAutistic behavior

FLG KANSL1 SETD5 NEXMIF RFX7 SPEN BBS12 FOXG1 MFF WAC

1.44e-046782110HP:0000729
HumanPhenoAbnormality of salivation

SETD5 NEXMIF TP63 IRAK1 SPEN FOXG1

1.68e-04215216HP:0100755
DomainS100_CABP

FLG RPTN HRNR FLG2

1.60e-0627604PS00303
DomainS_100

FLG RPTN HRNR FLG2

1.60e-0627604PF01023
DomainS100_Ca-bd_sub

FLG RPTN HRNR FLG2

1.86e-0628604IPR013787
DomainS100/CaBP-9k_CS

FLG RPTN HRNR FLG2

1.86e-0628604IPR001751
DomainS_100

FLG RPTN HRNR FLG2

1.86e-0628604SM01394
DomainFilaggrin

FLG FLG2

1.01e-052602IPR003303
DomainSPAR_C

SIPA1L1 SIPA1L3

3.04e-053602PF11881
DomainSIPA1L_C

SIPA1L1 SIPA1L3

3.04e-053602IPR021818
DomainAlk_phosphatase

ALPI ALPP

6.06e-054602PF00245
DomainAlkaline_phosphatase_AS

ALPI ALPP

6.06e-054602IPR018299
DomainAlkaline_phosphatase

ALPI ALPP

6.06e-054602IPR001952
DomainalkPPc

ALPI ALPP

6.06e-054602SM00098
DomainALKALINE_PHOSPHATASE

ALPI ALPP

6.06e-054602PS00123
DomainRap_GAP

SIPA1L1 SIPA1L3

4.49e-0410602PF02145
DomainRap_GAP_dom

SIPA1L1 SIPA1L3

5.48e-0411602IPR000331
DomainRAPGAP

SIPA1L1 SIPA1L3

5.48e-0411602PS50085
DomainEF_Hand_1_Ca_BS

FLG RPTN HRNR FLG2

2.41e-03175604IPR018247
DomainEF_HAND_1

FLG RPTN HRNR FLG2

4.18e-03204604PS00018
DomainAlkaline_phosphatase_core

ALPI ALPP

4.44e-0331602IPR017850
DomainAlkaline_Pase-like_a/b/a

ALPI ALPP

4.44e-0331602IPR017849
Domain-

ALPI ALPP

4.44e-03316023.40.720.10
DomainEF_HAND_2

FLG RPTN HRNR FLG2

6.47e-03231604PS50222
DomainEF_hand_dom

FLG RPTN HRNR FLG2

6.57e-03232604IPR002048
Pubmed

Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin.

FLG HRNR FLG2

5.66e-09363323403047
Pubmed

Interactomes of Glycogen Synthase Kinase-3 Isoforms.

MTUS1 SIPA1L1 SIPA1L3 ATG2B TNRC6A AKAP11

2.24e-0620963636779422
Pubmed

Human placental and intestinal alkaline phosphatase genes map to 2q34-q37.

ALPI ALPP

3.23e-0626323687940
Pubmed

Atopic Dermatitis Susceptibility Variants in Filaggrin Hitchhike Hornerin Selective Sweep.

FLG HRNR

3.23e-06263227678121
Pubmed

Placental and intestinal alkaline phosphatases are receptors for Aeromonas sobria hemolysin.

ALPI ALPP

3.23e-06263215715171
Pubmed

An ATIPical family of angiotensin II AT2 receptor-interacting proteins.

MTUS1 MTUS2

3.23e-06263220889352
Pubmed

Sipa1l3/SPAR3 is targeted to postsynaptic specializations and interacts with the Fezzin ProSAPiP1/Lzts3.

SIPA1L1 SIPA1L3

3.23e-06263226364583
Pubmed

Expression of filaggrin-2 protein in the epidermis of human skin diseases: a comparative analysis with filaggrin.

FLG FLG2

3.23e-06263224813994
Pubmed

HNF4 factors control chromatin accessibility and are redundantly required for maturation of the fetal intestine.

TP63 ALPI ALPP

5.38e-061963331345929
Pubmed

Variation in genes of the epidermal differentiation complex in German atopic dermatitis patients.

FLG HRNR FLG2

7.36e-062163319601998
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

KANSL1 SETD5 HIPK1 SIPA1L1 ZBTB43 SPEN ARAP2

8.99e-0640763712693553
Pubmed

The defect seen in the phosphatidylinositol hydrolysis pathway in HIV-infected lymphocytes and lymphoblastoid cells is due to inhibition of the inositol 1,4,5-trisphosphate 1,3,4,5-tetrakisphosphate 5-phosphomonoesterase.

ALPI ALPP

9.68e-0636321321014
Pubmed

Two gene duplication events in the evolution of the human heat-stable alkaline phosphatases.

ALPI ALPP

9.68e-0636323443302
Pubmed

Dissection of a QTL hotspot on mouse distal chromosome 1 that modulates neurobehavioral phenotypes and gene expression.

FCGR2A RGS7

9.68e-06363219008955
Pubmed

Role of lysophosphatidylcholine in brush-border intestinal alkaline phosphatase release and restoration.

ALPI ALPP

9.68e-06363219407215
Pubmed

Genomic structure and comparison of mouse tissue-specific alkaline phosphatase genes.

ALPI ALPP

9.68e-0636322286375
Pubmed

GATA3 regulates FLG and FLG2 expression in human primary keratinocytes.

FLG FLG2

9.68e-06363228928464
Pubmed

Intestinal Alkaline Phosphatase Regulates Tight Junction Protein Levels.

ALPI ALPP

9.68e-06363227106638
Pubmed

Organic pyrophosphates as substrates for human alkaline phosphatases.

ALPI ALPP

9.68e-06363216742561
Pubmed

Effects of disruption of the embryonic alkaline phosphatase gene on preimplantation development of the mouse.

ALPI ALPP

9.68e-06363210767088
Pubmed

MUSEAP, a novel reporter gene for the study of long-term gene expression in immunocompetent mice.

ALPI ALPP

9.68e-06363211722850
Pubmed

Filaggrin and filaggrin 2 processing are linked together through skin aspartic acid protease activation.

FLG FLG2

9.68e-06363232437351
Pubmed

Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk.

FLG KLK7

9.68e-06363218774391
Pubmed

Proteolytic activation of prochemerin by kallikrein 7 breaks an ionic linkage and results in C-terminal rearrangement.

KLK7 CMKLR1

9.68e-06363223495698
Pubmed

A novel phosphatase upregulated in Akp3 knockout mice.

ALPI ALPP

9.68e-06363217901166
Pubmed

RapGAPs in brain: multipurpose players in neuronal Rap signalling.

SIPA1L1 SIPA1L3

9.68e-06363220576033
Pubmed

Analysis of SPINK 5, KLK 7 and FLG genotypes in a French atopic dermatitis cohort.

FLG KLK7

9.68e-06363217989887
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

SEC16B INTS5 KANSL1 SIPA1L1 ZNF224 RFX7 DNMBP SPEN ALPI

1.03e-0577463915302935
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

CELSR1 INTS5 SETD5 IGHMBP2 SIPA1L1 SIPA1L3 TNRC6A DNMBP SPEN INO80D MFF FAM83B

1.35e-051497631231527615
Pubmed

Genetic variants associated with disordered eating.

FLG PDE8A CSMD1 FLG2

1.61e-058363423568457
Pubmed

Interactions between CD36 and global intestinal alkaline phosphatase in mouse small intestine and effects of high-fat diet.

ALPI ALPP

1.93e-05463221900644
Pubmed

Novel Role of the ALPI Gene Associated with Constipation Caused by Complement Component 3 Deficiency.

ALPI ALPP

1.93e-05463239273477
Pubmed

Structural evidence of functional divergence in human alkaline phosphatases.

ALPI ALPP

1.93e-05463212372831
Pubmed

Stage-specific expression patterns of alkaline phosphatase during development of the first arch skeleton in inbred C57BL/6 mouse embryos.

ALPI ALPP

1.93e-0546329061447
Pubmed

Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia.

ALPI ALPP

1.93e-0546329056646
Pubmed

Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.

SIPA1L1 SIPA1L3 TNRC6A HRNR SPEN

2.15e-0518463532908313
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

MTUS1 SIPA1L1 SIPA1L3 AKAP11 RFX7 DNMBP ARAP2 DOP1A FAM83B

2.40e-0586163936931259
Pubmed

Central role of pyrophosphate in acellular cementum formation.

ALPI ALPP

3.22e-05563222675556
Pubmed

The mouse homolog of the orphan nuclear receptor tailless is expressed in the developing forebrain.

DLX1 FOXG1

3.22e-0556327720587
Pubmed

Two alkaline phosphatase genes are expressed during early development in the mouse embryo.

ALPI ALPP

3.22e-0556322133555
Pubmed

Germ cell nuclear antigen (GCNA1) expression does not require a gonadal environment or steroidogenic factor 1: examination of GCNA1 in ectopic germ cells and in Ftz-F1 null mice.

ALPI ALPP

3.22e-0556329291464
Pubmed

A genomic atlas of mouse hypothalamic development.

INTS5 NEXMIF SIPA1L1 DLX1 FOXG1

3.61e-0520563520436479
Pubmed

Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.

SIPA1L1 CHD9 BSN SPEN DOP1A

3.87e-0520863533230847
Pubmed

N6-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation.

INTS5 SETD5 HIPK1 ATG2B INO80D

4.73e-0521763534048709
Pubmed

Expression of Cornified Envelope Proteins in Skin and Its Relationship with Atopic Dermatitis Phenotype.

FLG FLG2

4.82e-05663227304082
Pubmed

Sp8 is crucial for limb outgrowth and neuropore closure.

TP63 FOXG1

4.82e-05663214526104
Pubmed

Hydrolysis and absorption of pantothenate and its coenzymes in the rat small intestine.

ALPI ALPP

4.82e-0566326619987
Pubmed

Dissection of the odontoblast differentiation process in vitro by a combination of FGF1, FGF2, and TGFbeta1.

ALPI ALPP

4.82e-05663210878613
Pubmed

Emx1 and Emx2 functions in development of dorsal telencephalon.

DLX1 FOXG1

6.74e-0576329006071
Pubmed

Homeobox gene Dlx3 is regulated by p63 during ectoderm development: relevance in the pathogenesis of ectodermal dysplasias.

TP63 DLX1

6.74e-05763217164413
Pubmed

Replacement of Lost Lgr5-Positive Stem Cells through Plasticity of Their Enterocyte-Lineage Daughters.

ALPI ALPP

6.74e-05763226831517
Pubmed

Winged helix transcription factor BF-1 is essential for the development of the cerebral hemispheres.

DLX1 FOXG1

6.74e-0576327605629
Pubmed

Frizzled6 deficiency disrupts the differentiation process of nail development.

RPTN HRNR

6.74e-05763223439395
Pubmed

DYRK1A regulates the recruitment of 53BP1 to the sites of DNA damage in part through interaction with RNF169.

SIPA1L1 SIPA1L3 AKAP11 RFX7

7.32e-0512263430773093
Pubmed

The cell proliferation antigen Ki-67 organises heterochromatin.

DNAH3 INTS5 SIPA1L1 IRAK1 DNMBP SPEN

9.97e-0541063626949251
Pubmed

Regulation of Dlx5 and Dlx6 gene expression by p63 is involved in EEC and SHFM congenital limb defects.

TP63 DLX1

1.15e-04963218326838
Pubmed

microRNA-184 Induces a Commitment Switch to Epidermal Differentiation.

TP63 FLG2

1.15e-04963229198823
Pubmed

A Runx2/miR-3960/miR-2861 regulatory feedback loop during mouse osteoblast differentiation.

ALPI ALPP

1.15e-04963221324897
Pubmed

Prediction of the coding sequences of unidentified human genes. VIII. 78 new cDNA clones from brain which code for large proteins in vitro.

SIPA1L1 ZBTB43 BSN

1.17e-04526339455477
Pubmed

Complex arrangement of genes within a 220-kb region of double-duplicated DNA on human 2q37.1.

ALPI ALPP

1.44e-041063211352565
Pubmed

Multimodal spatiotemporal transcriptomic resolution of embryonic palate osteogenesis.

ALPI ALPP

1.44e-041063237709732
Pubmed

Epiboly generates the epidermal basal monolayer and spreads the nascent mammalian skin to enclose the embryonic body.

CELSR1 TP63

1.44e-041063226989131
Pubmed

Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche.

SEC16B PTPRN2 CSMD1 FAM83B

1.58e-0414963425231870
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

MTUS1 SETD5 SIPA1L1 TNRC6A IRAK1 CHD9 CSMD1 INO80D ARAP2

1.74e-04111663931753913
Pubmed

IFN-λ derived from nonsusceptible enterocytes acts on tuft cells to limit persistent norovirus.

ALPI ALPP

1.76e-041163237703370
Pubmed

A dual role for planar cell polarity genes in ciliated cells.

CELSR1 FOXG1

1.76e-041163225024228
Pubmed

A keratin scaffold regulates epidermal barrier formation, mitochondrial lipid composition, and activity.

KLK7 HRNR FLG2

1.98e-046263326644517
Pubmed

A YY1-dependent increase in aerobic metabolism is indispensable for intestinal organogenesis.

ALPI ALPP

2.11e-041263227802136
Pubmed

TNAP limits TGF-β-dependent cardiac and skeletal muscle fibrosis by inactivating the SMAD2/3 transcription factors.

ALPI ALPP

2.11e-041263231289197
Pubmed

Patterning of the dorsal telencephalon and cerebral cortex by a roof plate-Lhx2 pathway.

DLX1 FOXG1

2.11e-041263211719201
Pubmed

LncRNA SAMD12-AS1 promotes cell proliferation and inhibits apoptosis by interacting with NPM1.

FLG HRNR

2.11e-041263231406141
Pubmed

The Rb/E2F pathway modulates neurogenesis through direct regulation of the Dlx1/Dlx2 bigene cluster.

DLX1 FOXG1

2.49e-041363222699903
Pubmed

Establishment of smooth muscle and cartilage juxtaposition in the developing mouse upper airways.

TP63 FOXG1

2.49e-041363224218621
Pubmed

Dbx1-expressing cells are necessary for the survival of the mammalian anterior neural and craniofacial structures.

DLX1 FOXG1

2.49e-041363221552538
Pubmed

General transcription factor TAF4 antagonizes epigenetic silencing by Polycomb to maintain intestine stem cell functions.

ALPI ALPP

2.90e-041463236639541
Pubmed

Defects in Stratum Corneum Desquamation Are the Predominant Effect of Impaired ABCA12 Function in a Novel Mouse Model of Harlequin Ichthyosis.

KLK7 RPTN

2.90e-041463227551807
Pubmed

PRDM14 directly interacts with heat shock proteins HSP90α and glucose-regulated protein 78.

FLG HRNR

2.90e-041463229178343
Pubmed

C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.

PDE8A ATG2B AKAP11 MFF FAM83B LRP8

3.04e-0450463634432599
Pubmed

Expression of the winged helix genes fkh-4 and fkh-5 defines domains in the central nervous system.

IGHMBP2 DLX1

3.81e-04166328861101
Pubmed

TRIM30 modulates Interleukin-22-regulated papillary thyroid Cancer cell migration and invasion by targeting Sox17 for K48-linked Polyubiquitination.

HRNR FLG2

3.81e-041663231823782
Pubmed

Tracing the origin of adult intestinal stem cells.

ALPI ALPP

3.81e-041663231092921
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

INTS5 MTUS1 TNRC6A AKAP11 BSN DNMBP

3.93e-0452963614621295
Pubmed

MOF-mediated histone H4 Lysine 16 acetylation governs mitochondrial and ciliary functions by controlling gene promoters.

KANSL1 TP63

4.32e-041763237479688
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

HIPK1 SIPA1L1 SIPA1L3 ZBTB43 CHD9 ZNF224 USP9Y MTUS2 WAC

4.90e-04128563935914814
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

TNRC6A HRNR FLG2 SPEN MFF ARAP2 FAM83B

5.05e-0477763735844135
Pubmed

Multiple roles for HOXA3 in regulating thymus and parathyroid differentiation and morphogenesis in mouse.

TP63 FOXG1

5.41e-041963225249461
Pubmed

Dnmt1 is essential to maintain progenitors in the perinatal intestinal epithelium.

ALPI ALPP

6.01e-042063226023099
Pubmed

Differential expansion of zinc-finger transcription factor loci in homologous human and mouse gene clusters.

ZNF224 ZNF112

6.01e-042063212743021
Pubmed

Zinc-finger genes Fez and Fez-like function in the establishment of diencephalon subdivisions.

DLX1 FOXG1

6.01e-042063216971467
Pubmed

Distinct regulatory cascades govern extraocular and pharyngeal arch muscle progenitor cell fates.

ALPI ALPP

6.01e-042063219531352
Pubmed

TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity.

FLG HRNR FLG2

6.14e-049163334445801
Pubmed

The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.

SIPA1L1 SIPA1L3 TNRC6A BSN

6.70e-0421863433378226
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

HIPK1 TNRC6A BSN DNMBP SPEN FAM83B

6.84e-0458863638580884
Pubmed

Functional roles of Lgr4 and Lgr5 in embryonic gut, kidney and skin development in mice.

ALPI ALPP

7.97e-042363224680895
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

CELSR1 INTS5 KANSL1 SETD5 SIPA1L3 IRAK1 DNMBP SPEN

8.34e-04110563835748872
Pubmed

Emx2 directs the development of diencephalon in cooperation with Otx2.

DLX1 FOXG1

8.69e-042463211493561
Pubmed

A conserved Pbx-Wnt-p63-Irf6 regulatory module controls face morphogenesis by promoting epithelial apoptosis.

TP63 FOXG1

8.69e-042463221982646
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

MTUS1 SIPA1L1 SIPA1L3 TNRC6A IRAK1 DNMBP FAM83B

8.74e-0485363728718761
Pubmed

Pax6 limits the competence of developing cerebral cortical cells to respond to inductive intercellular signals.

DLX1 FOXG1

9.43e-042563236067211
Pubmed

Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.

ATG2B TNRC6A IRAK1 AKAP11

9.87e-0424263434011540
Cytoband1q21.3

FLG RPTN HRNR FLG2

2.12e-051176341q21.3
CytobandEnsembl 112 genes in cytogenetic band chr16p12

DNAH3 C16orf82 TNRC6A TMC5

9.54e-05172634chr16p12
CytobandEnsembl 112 genes in cytogenetic band chr1q21

FLG RPTN NBPF10 HRNR FLG2

2.38e-04404635chr1q21
Cytoband16p12.3

DNAH3 TMC5

1.01e-033463216p12.3
GeneFamilyEF-hand domain containing|S100 fused type protein family

FLG RPTN HRNR FLG2

8.76e-1074241350
GeneFamilyAlkaline phosphatases

ALPI ALPP

3.15e-0544221072
GeneFamilyEF-hand domain containing

FLG RPTN HRNR FLG2

1.63e-03219424863
ToppCellCOVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type

DNAH3 PTPRN2 CSMD1 RGS7 MTUS2

3.08e-061596355335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCellTCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9

KLK7 RPTN TP63 FLG2 FAM83B

6.80e-061876352ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

KANSL1 HIPK1 SPEN INO80D ARAP2

6.97e-06188635ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCellCOVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type

CELSR1 MTUS1 TP63 TMC5 FAM83B

7.16e-0618963584d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCellTracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations

KANSL1 SIPA1L3 TNRC6A RFX7 INO80D

9.19e-0619963594b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm|GW13 / Sample Type, Dataset, Time_group, and Cell type.

LRRC37A2 IRAK1 RFX7 MAP10 DNMBP

9.41e-062006350f4b8b0868bda406fe6bf01d1b722510fdfd0168
ToppCellControl-Epithelial_airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DNAH3 CELSR1 TMC5 FAM83B

7.42e-0515863435aee1c3b92169e73569331022833cb44ab7e7e8
ToppCellChildren_(3_yrs)-Epithelial-basal_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

CELSR1 ATOH8 TP63 FAM83B

7.42e-05158634d78e7e52657dc094430291fec07e9c298be9e584
ToppCellTCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9

INTS5 SIPA1L3 DNMBP LRP8

7.61e-05159634655c0749c238bd68cb797adb83e25a23b8a3cc9d
ToppCellChildren_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

PTPRN2 RGS7 MTUS2 FAM83B

9.20e-05167634c87ebfa8c3284ad33579190e148c95bcaf670d17
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DNAH3 CSMD1 TMC5 MTUS2

9.20e-051676343edb0570e583bb527165bcd8a4c25a042054043b
ToppCell3'_v3-GI_small-bowel-Lymphocytic_B|GI_small-bowel / Manually curated celltypes from each tissue

CELSR1 NEXMIF TP63 RGS7

9.41e-051686345535c1b8b7fde7b59a1bc0580cebdfa963aa1c39
ToppCell3'_v3-GI_small-bowel-Lymphocytic_B-Memory_B_cells|GI_small-bowel / Manually curated celltypes from each tissue

CELSR1 NEXMIF TP63 RGS7

9.41e-051686348e025bb0541746e232b77ac0e31412ae71420c47
ToppCelldroplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KLK7 KANSL1 HIPK1 SPEN

9.63e-051696344e1322cc5e1733e9fb19e08f739a30206f43cea8
ToppCell5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TP63 CSMD1 FLG2 FAM83B

9.85e-051706342d880223d01bde4bf777bd6f50b7d2768489075f
ToppCell5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TP63 CSMD1 FLG2 FAM83B

9.85e-051706340cc20322cb3e3e7bbd4daad8785c99f80e355c16
ToppCell3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DLX1 RFX7 DOP1A LRP8

1.01e-04171634b51bbeacb172e8b5de519ada85543d7ae9914b3c
ToppCelldroplet-Fat-Bat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SEC16B MTUS1 CSMD1 BBS12

1.10e-04175634b4f01e7782cdd107d0817ef601891fd3a382bc35
ToppCelldroplet-Fat-Bat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SEC16B MTUS1 CSMD1 BBS12

1.10e-04175634ef6f811d8e1839f405c3b41090ddf79be57a099f
ToppCellFetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal-GABAergic_neurons|GW10 / Sample Type, Dataset, Time_group, and Cell type.

CBLL2 RPTN TP63 DLX1

1.10e-04175634d4ff1f197ad4086286e86817cbff24fa718293fc
ToppCelldroplet-Fat-Bat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SEC16B MTUS1 CSMD1 BBS12

1.10e-041756347f7598d46d10bff1cbea42f950bdde1aaa16e9a4
ToppCellLPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

IGSF10 MTUS1 ATOH8 USP9Y

1.15e-04177634b7fee75de7e96924af488a5baa2334711889ae7c
ToppCell356C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

MTUS1 LRRC37A2 ZNF224 TMC5

1.15e-0417763436b5d29caa9cffbc0284f771a4db71aa72171a89
ToppCellCOVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations)

CELSR1 MTUS1 NEXMIF TMC5

1.36e-04185634cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell343B-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

MTUS1 PTPRN2 SIPA1L1 ZNF224

1.39e-0418663476cbc3610aedf8c19c17ad5faf6ef5e8980b6af5
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CELSR1 MTUS1 ATOH8 SIPA1L3

1.42e-0418763458d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell367C-Epithelial_cells-Epithelial-H_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells)

CELSR1 TP63 TMC5 FAM83B

1.45e-0418863461422c7919ca0ea02d6be4302f11b169a3ce35e5
ToppCell10x5'-GI_large-bowel-Myeloid_Monocytic|GI_large-bowel / Manually curated celltypes from each tissue

FCGR2A ATOH8 CMKLR1 ZNF112

1.45e-04188634d0045fdda757d191dabc7853f6a6e99c0e97d93d
ToppCell367C-Epithelial_cells-Epithelial-H_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells)

CELSR1 TP63 TMC5 FAM83B

1.45e-0418863418698f0b22ccbc2b93759acc1c8dbdb30a6b5a16
ToppCell10x5'-GI_large-bowel-Myeloid_Monocytic-Classical_monocytes|GI_large-bowel / Manually curated celltypes from each tissue

FCGR2A ATOH8 CMKLR1 ZNF112

1.45e-041886340bcf04aa47738f43c1a87dae5dc487738ee86f8c
ToppCellTCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9

KLK7 RPTN TP63 FLG2

1.51e-04190634e2b26a03c6ab24d9b0f4150c47597be37767d86e
ToppCellTCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9

KLK7 RPTN TP63 FLG2

1.51e-0419063401fb45add4661bc86cd0a34fac35177907152dbb
ToppCellCOVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations)

CELSR1 MTUS1 NEXMIF TMC5

1.51e-0419063451ca9ef4df3220487152fcf684147730637c7cc1
ToppCellTCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9

KLK7 RPTN TP63 FLG2

1.51e-041906343188c7bd225cbcf46a21e2fb784336cdd9665995
ToppCellCOPD-Myeloid-cDC2|World / Disease state, Lineage and Cell class

SIPA1L1 SIPA1L3 CSMD1 DNMBP

1.54e-041916344e4887175200a57e1b041f2f131e3df774df3509
ToppCellCOPD-Myeloid-cDC2|COPD / Disease state, Lineage and Cell class

SIPA1L1 SIPA1L3 CSMD1 DNMBP

1.54e-041916342af6e4a6bd1f2193ece2131c3b7d976dd23a6966
ToppCellCOPD-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class

SIPA1L1 SIPA1L3 CSMD1 DNMBP

1.57e-04192634984cdc2f1d93e164bc946d63f58dacb629f82eb7
ToppCellLV-08._Macrophage|LV / Chamber and Cluster_Paper

FCGR2A SIPA1L1 CMKLR1 ARAP2

1.57e-041926347be12d580aaf2f2f1562203fcad3a44639b8c5a6
ToppCellEpithelial-club_cell|World / Lineage, Cell type, age group and donor

CELSR1 MTUS1 NEXMIF TMC5

1.60e-041936342bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCellCOPD-Myeloid-Macrophage|World / Disease state, Lineage and Cell class

FCGR2A SIPA1L1 CSMD1 DNMBP

1.64e-041946347d682408e9a6239a4e47befc9376e760cc3d133a
ToppCellsevere-B_cell|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

CELSR1 TP63 RGS7 DOP1A

1.67e-041956340fc3c605609c9e6bdea15d73c45def2188ae5fb1
ToppCellBronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations

KANSL1 SIPA1L1 SIPA1L3 RFX7

1.70e-04196634ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCellMid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PTPRN2 CSMD1 RGS7 MTUS2

1.70e-04196634676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCellNS-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

FLG KLK7 MTUS1 RPTN

1.70e-04196634453c809494ceffa2a28af283c4b5a4924fcf160f
ToppCellLPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type

IGSF10 MTUS1 ATOH8 CHD9

1.74e-041976340a6550dce156fc81f15b1e7830d331ca50d87d06
ToppCellSomatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PTPRN2 CSMD1 RGS7 MTUS2

1.77e-04198634c01091ef18e096d792ea2a7a715764a5b215355f
ToppCellprimary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PTPRN2 CSMD1 RGS7 MTUS2

1.77e-041986346d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PTPRN2 CSMD1 RGS7 MTUS2

1.77e-041986348ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCellFetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

CELSR1 MTUS1 NEXMIF TMC5

1.77e-041986346ba5e5970109a04ed968bac7ff099ae250c579dc
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PTPRN2 CSMD1 RGS7 MTUS2

1.77e-041986340ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster

CHD9 DLX1 FOXG1 LRP8

1.77e-04198634de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCellFetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

CELSR1 MTUS1 NEXMIF TMC5

1.77e-041986345fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PTPRN2 CSMD1 RGS7 MTUS2

1.77e-041986344ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCellParenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CELSR1 MTUS1 SIPA1L3 TMC5

1.80e-041996345cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type.

AKAP11 DLX1 BSN FOXG1

1.80e-04199634b2d7dea11207cca63d688f8051143850b29dbdf0
ToppCellTransverse-Macrophage-LYVE1_Macrophage|Transverse / Region, Cell class and subclass

FCGR2A CMKLR1 FLG2 ZNF491

1.80e-04199634facf79c256db5ae57bdb613e86ec90616a6f67ca
ToppCellTransverse-(6)_Macrophage-(61)_LYVE1_Macrophage|Transverse / shred on region, Cell_type, and subtype

FCGR2A CMKLR1 FLG2 ZNF491

1.80e-04199634dcc2a7f4d1fa30aaaad655dd59c5a2b039d264bf
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class

NBPF10 CMKLR1 USP9Y ARAP2

1.84e-042006342281debd86e5d92e8fe0397aec9ef670800f7471
ToppCellNeuronal|World / cells hierarchy compared to all cells using T-Statistic

PTPRN2 CSMD1 RGS7 MTUS2

1.84e-0420063448d801219bc771d6c7e151dc88ca4c179988de85
ToppCelllung-Type_I_Pneumocytes|lung / shred on tissue and cell subclass

KLK7 KANSL1 FCGR2A

2.14e-04826336023212a51f8b3e05e6c3dcf4e8fbf53ba696fb2
Drugdioxetane

TP63 PISD ALPI ALPP

1.12e-0629624CID000122029
Drugphotobiotin

FCGR2A ALPI ALPP

2.28e-0610623CID003035428
Drug4-aminophenyl phosphate

ALPI ALPP

7.30e-062622CID000122270
Drug3-(hydroxymethyl)phenytoin

ALPI ALPP

7.30e-062622ctd:C043104
Drug5-bromo-4-chloroindoxyl

ALPI ALPP

7.30e-062622CID009964843
Drugfast red violet LB salt

ALPI ALPP

7.30e-062622CID006370075
Drug5-hydroxycytidine

ALPI ALPP

2.18e-053622CID000198207
DrugAlphostatin

ALPI ALPP

2.18e-053622CID000174788
Drug3-indoxyl phosphate

ALPI ALPP

4.36e-054622CID000026292
Drugp-bromotetramisole

ALPI ALPP

4.36e-054622CID000005121
Drugammediol

ALPI ALPP

4.36e-054622CID000001531
DrugFast Blue RR Base

ALPI ALPP

4.36e-054622CID000080442
DrugSb15

ALPI ALPP

4.36e-054622CID000044950
Drugnaphthol AS phosphate

ALPI ALPP

4.36e-054622CID000084137
Drugethylethanolamine

ALPI ALPP

4.36e-054622CID000008072
DrugFast Blue RR

ALPI ALPP

7.26e-055622CID000093116
DrugSMR 6

ALPI ALPP

7.26e-055622CID006439864
Drugdendrodoine

ALPI ALPP

7.26e-055622CID000126514
Drugranelic acid

ALPI ALPP

7.26e-055622CID003052774
Drugmitomycin phosphate

ALPI ALPP

7.26e-055622CID000130219
Drug6-thioxanthosine

ALPI ALPP

7.26e-055622CID004023632
Drugnaphthol AS-TR phosphate

ALPI ALPP

1.09e-046622CID000075794
DrugO,O,S-trimethylphosphorodithioate

ALPI ALPP

1.09e-046622CID000018065
Drug5-fluorosalicylic acid

ALPI ALPP

1.09e-046622CID000067658
DrugFADP

ALPI ALPP

1.09e-046622CID003081481
Druglead;sulfide

ALPI ALPP

1.09e-046622CID009794739
DrugDSCG

PTPRN2 ALPI ALPP

1.29e-0436623CID003011861
DrugLaurdan

FCGR2A TP63 FOXG1

1.52e-0438623CID000104983
Drugnitrophenylphosphate

ALPI ALPP

1.52e-047622ctd:C008644
Drugp-aminodiphenylamine

ALPI ALPP

1.52e-047622CID000007564
DrugFlutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A

MTUS1 HIPK1 SIPA1L3 ZBTB43 INO80D

1.86e-041946254361_DN
DrugMefexamide hydrochloride [3413-64-7]; Up 200; 12.6uM; PC3; HT_HG-U133A

INTS5 MTUS1 ZBTB43 ZNF224 INO80D

1.91e-041956252121_UP
DrugIsoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A

CELSR1 INTS5 ZBTB43 TMC5 DNMBP

1.95e-041966252056_DN
DrugFluorocurarine chloride [22273-09-2]; Down 200; 11.6uM; HL60; HT_HG-U133A

INTS5 IGHMBP2 SIPA1L1 INO80D ARAP2

1.95e-041966252521_DN
DrugTicarcillin sodium [4697-14-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A

IGHMBP2 KREMEN2 PISD TMC5 DNMBP

2.00e-041976257185_DN
Drugfosfosal

ALPI ALPP

2.02e-048622CID000003418
Drugiopentol

ALPI ALPP

2.02e-048622CID000056016
Drugsodium monofluorophosphate

SPEN ALPI

2.02e-048622CID000024266
Drug(1S,2E,3S)-2-[(2E)-2-[(7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-3-methyl-cyclohexanol

ALPI ALPP

2.02e-048622CID011953890
Drugorellanine

ALPI ALPP

2.02e-048622CID000089579
DrugHydroflumethiazide [135-09-1]; Up 200; 12uM; HL60; HT_HG-U133A

PTPRN2 SIPA1L3 DNMBP INO80D DOP1A

2.05e-041986251851_UP
DrugChlorprothixene hydrochloride [6469-93-8]; Up 200; 11.4uM; HL60; HT_HG-U133A

DNAH3 MTUS1 SIPA1L1 DNMBP INO80D

2.05e-041986251272_UP
DrugCP-320650-01 [172079-28-6]; Up 200; 10uM; PC3; HT_HG-U133A

CT62 PTPRN2 TP63 ZBTB43 USP9Y

2.10e-041996253822_UP
DrugN6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Down 200; 2uM; MCF7; HT_HG-U133A_EA

MTUS1 IGHMBP2 SIPA1L3 RFX7 DOP1A

2.10e-04199625959_DN
Druglissamine

MFF ALPI ALPP

2.35e-0444623CID005359521
Drugaminohexane

ALPI ALPP

2.59e-049622CID000201427
Drugphenolphthalein monophosphate

ALPI ALPP

2.59e-049622CID000128862
DrugR 8231

ALPI ALPP

2.59e-049622CID003084926
DrugPonceau S solution

ALPI ALPP

2.59e-049622CID005473620
DrugAphos

ALPI ALPP

2.59e-049622CID000053051
Drugpingyangmycin

TP63 FOXG1

2.59e-049622CID000084046
Drugfosfluconazole

ALPI ALPP

2.59e-049622CID000214356
Drugnaphthol AS-TR

ALPI ALPP

2.59e-049622CID000066718
Drugthymol

SPEN ALPI ALPP

2.69e-0446623CID000006989
DiseaseNeurodevelopmental Disorders

SETD5 NEXMIF FOXG1 WAC

3.94e-0593604C1535926
Diseaseheart rate

CELSR1 TP63 SIPA1L1 TNRC6A CSMD1

9.57e-05225605EFO_0004326
Diseasepostburn hypertrophic scarring severity measurement

CSMD1 ARAP2

1.81e-0410602EFO_0007747
Diseasediffuse scleroderma (is_implicated_in)

FCGR2A IRAK1

2.21e-0411602DOID:1580 (is_implicated_in)
Diseasetriacylglycerol 44:1 measurement

C16orf82 CSMD1

2.65e-0412602EFO_0010399
Diseasetriacylglycerol 46:2 measurement

C16orf82 CSMD1

3.64e-0414602EFO_0010402
DiseaseCongenital total cataract

SIPA1L3 DNMBP

4.79e-0416602C0266539
Diseaseresponse to triptolide, cytotoxicity measurement

CSMD1 MTUS2

4.79e-0416602EFO_0006952, EFO_0007662
Diseasephosphatidylcholine 40:6 measurement

CSMD1 TMC5

5.42e-0417602EFO_0010389
Diseasetriacylglycerol 48:1 measurement

C16orf82 CSMD1

5.42e-0417602EFO_0010404
Diseaseresponse to methotrexate, juvenile idiopathic arthritis

CMKLR1 CSMD1

6.80e-0419602EFO_0002609, GO_0031427
Diseasetriacylglycerol 46:1 measurement

C16orf82 CSMD1

7.55e-0420602EFO_0010401
Diseasenighttime rest measurement

SEC16B CSMD1

1.09e-0324602EFO_0007827
Diseasetriacylglycerol 48:0 measurement

C16orf82 CSMD1

1.28e-0326602EFO_0010403
Diseaseage at menarche

SEC16B PTPRN2 TNRC6A CSMD1 BSN FAM83B

1.29e-03594606EFO_0004703
Diseasecholesteryl ester 14:0 measurement

PTPRN2 RGS7

1.38e-0327602EFO_0010340
Diseaseneuroimaging measurement

CELSR1 KANSL1 PDE8A TP63 TNRC6A TMC5 FOXG1 LRP8

1.39e-031069608EFO_0004346

Protein segments in the cluster

PeptideGeneStartEntry
NPDQDSSSHYHGTSS

CSMD1

3471

Q96PZ7
TFSIPQANHSHSGDY

FCGR2A

171

P12318
LQPSSQNHRFYHSTG

AKAP11

1511

Q9UKA4
YSHIPVDSNHNFRSS

DOP1A

1436

Q5JWR5
YNPRRSHSDASVGSH

DNMBP

1346

Q6XZF7
VNRHSYPLSSTSGNA

ARAP2

446

Q8WZ64
HSAGHSQPDGAYSSA

DLX1

46

P56177
DANTHRPVFQSSHYT

CELSR1

781

Q9NYQ6
GYHHSHTTPQGRSDA

FLG

1516

P20930
FRHSQHGSVSYNSNP

FLG

3991

P20930
HHLQNATDSGSPSSY

BBS12

621

Q6ZW61
QNGNPSASEFASHHY

CBLL2

346

Q8N7E2
VSQESGPTYASFSHH

ATG2B

1461

Q96BY7
GNTNSSEPENRTHFH

MTUS2

61

Q5JR59
AENSHSHSDYINASP

PTPRN2

791

Q92932
SHVIYNNHQDSSASP

ATOH8

196

Q96SQ7
HESTSSQSLGYDQHG

FLG2

456

Q5D862
HESRSGQSSYGQHSS

FLG2

761

Q5D862
SGFGQHESRSHQSSY

FLG2

831

Q5D862
TRHSYSGHEQTTQTG

FLG2

1551

Q5D862
YSDSEGHSGFSQRPH

FLG2

1806

Q5D862
HDSSSRTENPKHSQY

MAP10

726

Q9P2G4
NTNYNHPHEADSAGT

LRRC37A2

1416

A6NM11
ATSNPHHDNVRYGIS

MFF

261

Q9GZY8
DESNSEPHSQSSYRH

MTUS1

316

Q9ULD2
QGSSRHAAAYTTHPS

HIPK1

1136

Q86Z02
SQPSRASSAYHHASD

BSN

3706

Q9UPA5
ASSSREGYVSHHNTP

FAM83B

426

Q5T0W9
EGYVSHHNTPAQSFA

FAM83B

431

Q5T0W9
LHHPRASSTLSYNGT

FOXG1

316

P55316
SSNPYHNSTHSADVL

PDE8A

551

O60658
QSSSYGQHESASRHS

HRNR

396

Q86YZ3
QHDSSSGQSSSYGQH

HRNR

856

Q86YZ3
SGQSSSYGQHESASH

HRNR

861

Q86YZ3
SKSFRHPGYSTQTHV

KLK7

96

P49862
SSHSLSEYSHGQSPR

KANSL1

976

Q7Z3B3
TQQHSYSSASDPHGR

KREMEN2

66

Q8NCW0
SHDSGNFQHRISSSP

OVOS2

481

Q6IE36
SPQENSYVSSTGRAH

IRAK1

541

P51617
QHASPAGTYAHTVNR

ALPI

171

P09923
TRVQHASPAGTYAHT

ALPP

171

P05187
NGSSSTSPYNTDHAQ

TP63

126

Q9H3D4
HSSHPQGNYSNSKLS

CHD9

341

Q3L8U1
VSEPRHNHFYSHTTQ

IGSF10

961

Q6WRI0
HHHRGPSDSIANNYS

DNAH3

101

Q8TD57
TSRQQYSSDHSHSSP

INO80D

811

Q53TQ3
SSPEEVFHSGHSRNS

FAM102A

216

Q5T9C2
VFHSGHSRNSSYASQ

FAM102A

221

Q5T9C2
TDQPSAYSHTHRTFS

CT62

16

P0C5K7
PGTTVHRSTYQNHST

LRP8

761

Q14114
HRSTYQNHSTETPSL

LRP8

766

Q14114
YGLQNDIRSHSPTHT

RGS7

231

P49802
TYSNSHGSYDSNQPH

NBPF10

481

Q6P3W6
NNTSISYFSHHSPEQ

NEXMIF

826

Q5QGS0
SYFSHHSPEQNEGSL

NEXMIF

831

Q5QGS0
PNKQGHSDSHYSSHS

SIPA1L1

1271

O43166
NRHSKGEPQYSSHSS

SIPA1L3

1256

O60292
SAVSNSQHYPHRGSG

SETD5

1406

Q9C0A6
GGTSYSPQENSHNHS

WAC

91

Q9BTA9
SSTYSGQHQRVPHAT

INTS5

156

Q6P9B9
NALSEDTGHSSYPSH

CMKLR1

336

Q99788
HGSDHQSPSSSSYNG

ZBTB43

136

O43298
NYQHSRSRSPHSSQS

SPEN

236

Q96T58
YSHENSQGSSHAATK

IGHMBP2

651

P38935
DLHTNSPRHSKGSYN

PISD

336

Q9UG56
PGQSYQSQSRHHDTH

RFX7

1006

Q2KHR2
SDSSTASPGNHRNHY

USP9Y

981

O00507
HYENQHSPFGTNSET

SEC16B

161

Q96JE7
SYLQSHQSVHSGERP

ZNF112

706

Q9UJU3
YSPSSFQRHERSHTG

ZNF491

281

Q8N8L2
SSSGNYAGSRTHPDH

TMC5

141

Q6UXY8
TNSQCYSHQRSHSGE

ZNF224

411

Q9NZL3
SSHYSQTDRQGQSSH

RPTN

316

Q6XPR3
SSHYGQPDTQDQSSH

RPTN

376

Q6XPR3
SSHYGQPDRQGQNSH

RPTN

436

Q6XPR3
IYGVTSPQRGHSQHS

C16orf82

41

Q7Z2V1
SDINHSTSGSHYENS

TNRC6A

196

Q8NDV7
HYENSQRGPVSSTSD

TNRC6A

206

Q8NDV7